Comparison between insulin tolerance test, growth hormone (GH)-releasing hormone (GHRH), GHRH plus acipimox and GHRH plus GH-releasing peptide-6 for the diagnosis of adult GH deficiency in normal subjects, obese and hypopituitary patients.
about
The decreased growth hormone response to growth hormone releasing hormone in obesity is associated to cardiometabolic risk factors.Does the pituitary somatotrope play a primary role in regulating GH output in metabolic extremes?The effects of central adiposity on growth hormone (GH) response to GH-releasing hormone-arginine stimulation testing in men.Diagnosis and treatment of adrenal insufficiency in the critically ill patient.Niacin: a re-emerging pharmaceutical for the treatment of dyslipidaemia.Reduced growth hormone secretion is associated with increased carotid intima-media thickness in obesity.Growth hormone/insulin-like growth factor-I axis in obstructive sleep apnea syndrome: an update.Approved and Off-Label Uses of Obesity Medications, and Potential New Pharmacologic Treatment Options.Pituitary growth hormone (GH) secretion is partially rescued in HIV-infected patients with GH deficiency (GHD) compared to hypopituitary patients.A pilot study of the effects of niacin administration on free fatty acid and growth hormone concentrations in children with obesity.Preoperative prediction of growth hormone (GH)/insulin-like growth factor-1 (IGF-1) axis modification and postoperative changes in candidates for bariatric surgery.Effects of Bariatric Surgery on Change of Brown Adipocyte Tissue and Energy Metabolism in Obese Mice.The Third International Symposium on Obesity and Hypertension ISOH'03: 'Genetics and Molecular Mechanisms' (October 23-25, 2003, Berlin Germany).Treatment with Growth Hormone for Adults with Growth Hormone Deficiency Syndrome: Benefits and Risks.
P2860
Q33633368-1716C437-31EE-4E91-BB30-78460344D4DFQ36240950-36BC11AD-F4DB-44C2-99D4-B9112900C692Q36971944-E208F091-56A8-49CF-916A-8E1CA0D50E72Q36982683-18C92F3F-B609-4198-A9CF-46BA58293155Q37376937-65236934-8B19-433A-B8AE-8C563969ADD4Q37482792-086229B5-882E-4C28-8E9E-5B57D65D8255Q37737002-D2D72677-C238-4E82-B44B-E46780BA6C45Q38818675-F4C95DC6-DDB0-4C61-8990-5010A8732690Q38972764-8EBA6414-EB10-43E4-AA5F-CEF532194623Q39365340-7F09519A-3698-4F8E-BFF8-3198F70ADF25Q42678045-A9A8FFDB-BB55-449B-848F-1D30634AB250Q47789013-EC42D475-8B41-4FE3-8F70-9103EE987FEBQ52939180-94BA52BE-E1CC-4836-9ABF-58FE5B40A849Q55349083-FE5E749A-E882-499F-82D6-CCEE5B051A13
P2860
Comparison between insulin tolerance test, growth hormone (GH)-releasing hormone (GHRH), GHRH plus acipimox and GHRH plus GH-releasing peptide-6 for the diagnosis of adult GH deficiency in normal subjects, obese and hypopituitary patients.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Comparison between insulin tol ...... se and hypopituitary patients.
@en
Comparison between insulin tol ...... se and hypopituitary patients.
@nl
type
label
Comparison between insulin tol ...... se and hypopituitary patients.
@en
Comparison between insulin tol ...... se and hypopituitary patients.
@nl
prefLabel
Comparison between insulin tol ...... se and hypopituitary patients.
@en
Comparison between insulin tol ...... se and hypopituitary patients.
@nl
P2093
P356
P1476
Comparison between insulin tol ...... ese and hypopituitary patients
@en
P2093
Carlos Dieguez
Felipe F Casanueva
Maria Luisa Isidro
Paula Alvarez-Castro
P304
P356
10.1530/EJE.0.1490117
P577
2003-08-01T00:00:00Z